Proteolysis in colorectal cancer

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 3, 1999, Pages 140-145

  Garbett, E A ^a   Reed, M W R ^b   Brown, N J ^c  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c NONE

Author keywords

Colorectal cancer; Metastasis; Proteolysis

Indexed keywords

ALTEPLASE; CASEIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UROKINASE;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CANCER; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; ZYMOGRAPHY;

EID: 0033001507     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.3.140     Document Type: Article

References (32)

1. 1 Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
2. 2 Yu AE, Hewitt RE, Connor EW, et al. Matrix metalloproteinases: novel targets for directed cancer therapy. Drugs Ageing 1997;11;229-44.
3. 3 Baici A, Gyger-Marazzi M, Strauli P. Extracellular cysteine proteinase and collagenase activities as a consequence of tumour host interaction in the rabbit V2 carcinoma. Invasion Metastasis 1984;4:13-27.
4. 4 Thorpe SM, Rochefort H, Garcia M, et al. Association between high concentrations of MR 52,000 cathepsin D and poor prognosis in primary breast cancer. Cancer Res 1989;49:6008-14.
5. 5 Duffy MJ, O' Grady P, Devansey D, et al. Tissue type plasminogen activator, a new prognostic marker in breast cancer. Cancer Res 1988;48:1348-9.
6. 6 Stetler-Stevenson WG, Liotta LA, Kleiner DE. Extracellular matrix 6: role of matrix metalloproteinases in human invasion and metastasis. FASEB J 1993;7:1434-41.
7. 7 Woessner JF. The family of matrix metalloproteinases. Ann N Y Acad Sci 1993;732:11-21.
8. 8 Kwaan HC. The plasminogen - plasmin system in malignancy. Cancer Metastasis Rev 1992;11:291-311.
9. 9 Matrisian LM, Wright J, Newell K, et al. Matrix degrading metalloproteinases in tumour progression. Princess Takamatsu Symp 1994;24:152-61.
10. 10 Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase-1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 1995;72:575-82.
11. 11 Liabakk NB, Talbot I, Smith RA, et al. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996; 56:90-106.
12. 12 Hewitt RE, Leach IH, Powe DG: et al. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 1991;49:666-72.
13. 13 Gallegos NC, Smales C, Savage FJ, et al. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 1995;4:111-19.
14. 14 Zucker S, Lysik RM, Zarrabi MH, et al. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140-6.
15. 15 Levy AT, Cioce V, Sobel ME, et al. Increased expression of the Mr 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res 1991;51:439-44.
16. 16 Parsons SL, Collins HM, Clarke PA, et al. Expression of matrix metalloproteinases in colorectal adenomas and carcinomas. Br J Surg 1996;83:1652.
17. 17 Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-96.
18. 18 Zeng ZS, Huang Y, Cohen AM, et al. Prediction of colon cancer relapse and survival via tissue mRNA levels of matrix metalloproteinase-9. J Clin Oncol 1996;14:3133-40.
19. 19 Zeng ZS, Guillem JG. Colocalisation of MMP-9 RNA and protein in human colorectal cancer stromal cells. Br J Cancer 1996;74:1161-7.
20. 20 Murray GI, Duncan ME, O'Neil P, et al. MMP-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
21. 21 Grondahl-Hansen J, Ralfkiaer E, Kirkeby LT, et al. Localisation of urokinase type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 1991;138:111-17.
22. 22 Pyke C, Kristensen P, Ralfiaer E, et al. Urokinase-type plasminogen activator is expressed in stromal cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991;138:1059-67.
23. 23 Buo L, Meling GI, Karlsrud TS, et al. Artigen levels of urokinase plasminogen activator and its receptor at the tumour host interface of colorectal adenocarcinomas are related to aggressiveness. Hum Pathol 1995;26:1133-38.
24. 24 Murashige M, Miyakara M, Shiraishu N, et al. Enhanced expression of tissue inhibitors of metalloproteinases in human colon tumours. Jpn J Clin Oncol 1996;26:303-9.
25. 25 Ring P, Johasson H, Hoyhtya M, et al. Expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in human colon cancer: a predictor of tumour stage. Br J Cancer 1997;76:805-11.
26. 26 Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerised substrates. Anal Biochem 1980;102:196-202.
27. 27 Seftor REB, Electrophoretic analysis of proteins associated with tumour cell invasion. Electrophoresis 1994;15:454-62.
28. 28 Brown CJ, Rahman S, Morton AC, et al. Inhibitors of collagenase hut not gelatinase reduce cartilage explant proteoglycan breakdown despite only low levels of matrix metalloproteinase activity. J Clin Pathol: Mol Pathol 1996;49:M331-9.
29. 29 Knight CG: Willenbrock F, Murphy G. A novel coumarinlabelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992;296:263-6.
30. 30 Gelister J, Mahmoud M, Lewin MR, et al. Plasminogen activators in human colorectal neoplasms. BMJ 1986;293: 728-31.
31. 31 Yoshimoto M, Itoh F, Yamamoto H, et al. Expression of MMP-7 (pump-1) mRNA in human colorectal cancer. Int J Cancer 1993;54:614-18.
32. 32 Ohtani H, Motohashi H, Sato H, et al. Dual over expression pattern of membrane type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinomas revealed by in situ-hybridisation and immuno-electron microscopy. Int J Cancer 1996;68:567-70.